BAM
DGX icon

Berkshire Asset Management’s Quest Diagnostics DGX Stock Holding History

Berkshire Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$512K Sell
2,414
-216
-8% -$42.4K 0.02% 182
2026
Q1 		$515K Buy
2,630
+38
+1% +$7.38K 0.02% 175
2025
Q4 		$450K Buy
2,592
+102
+4% +$18.6K 0.02% 185
2025
Q3 		$475K Buy
2,490
+1,030
+71% +$183K 0.02% 199
2025
Q2 		$262K Hold
1,460
– – 0.01% 247
2025
Q1 		$257K Hold
1,460
– – 0.01% 252
2024
Q4 		$227K Buy
+1,460
New +$227K 0.01% 259
2024
Q1 		– Sell
-1,484
Closed -$205K – 235
2023
Q4 		$205K Buy
+1,484
New +$195K 0.01% 225
2023
Q3 		– Sell
-1,491
Closed -$210K – 226
2023
Q2 		$210K Sell
1,491
-8
-0.5% -$1.1K 0.01% 223
2023
Q1 		$212K Buy
+1,499
New +$214K 0.01% 217
2022
Q3 		– Sell
-1,658
Closed -$220K – 224
2022
Q2 		$220K Sell
1,658
-762
-31% -$104K 0.01% 210
2022
Q1 		$331K Hold
2,420
– – 0.02% 168
2021
Q4 		$419K Sell
2,420
-440
-15% -$66.9K 0.03% 178
2021
Q3 		$416K Buy
2,860
+615
+27% +$90K 0.03% 178
2021
Q2 		$296K Sell
2,245
-52
-2% -$6.81K 0.02% 196
2021
Q1 		$295K Buy
+2,297
New +$283K 0.02% 184

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Berkshire Asset Management's DGX Position: Q2 2026 in Review

Berkshire Asset Management reduced its Quest Diagnostics (DGX) stake by 8.2% in Q2 2026, selling an estimated $42.4K and leaving 2,414 shares worth $512K. The position accounts for 0.02% of the portfolio, ranked #182.

Berkshire Asset Management first reported a position in DGX in Q1 2021 and has held it in 16 quarters since. The position peaked at $515K in Q1 2026. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Berkshire Asset Management held 2,414 shares of Quest Diagnostics worth $512K as of Q2 2026.
  • Berkshire Asset Management sold 216 Quest Diagnostics shares in Q2 2026, an estimated $42.4K.
  • Quest Diagnostics made up 0.02% of Berkshire Asset Management's portfolio in Q2 2026, its #182 holding.
  • Berkshire Asset Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 16 quarters since.
  • Berkshire Asset Management's Quest Diagnostics position peaked at $515K in Q1 2026.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Berkshire Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.